Polski
 
 
 
 
Home› NEWS
NEWS
 
New safety FDA information on statin therapy!
 
 
What awaits us regarding lipid disorders in 2012?
 
 
Co-operation between PoLA and Archives of Medical Science and American Society for Preventive Cardiology (ASPC)
 
 
Addressing Residual Risk in the ACS Patient: Knowing the Numbers!
 
 
Merry Christmas and Happy New Year AD 2012!
 
 
Large discussion on AIM-HIGH
 
 
Should we use statins in elderly population?
 
 
Despite robust clinical trial evidence, a substantial number of patients with obstructive CAD remain untreated with statins!
 
 
Maximum doses of rosuvastatin and atorvastatin equally regress atherosclerosis - results of SATURN Trial
 
 
Blood Pressure, Lipids and Glucose in Type 2 Diabetes - How Low Should We Go?
 
 
Board Meeting of National Lipid Assocation (NLA), 12th Nov. 2011, Orlando
 
 
Board Meeting of American Society of Preventive Cardiology (ASPC) - Orlando, 12th Novembr 2011.
 
 
Cautious Optimism Welcomes New CETP Inhibitor - evacetrapib
 
 
Statins Are Safe and Effective - 11-year follow-up of HPS study
 
 
I Congress of Polish Lipid Association (PoLA) - Warsaw, September 2011.
 
 
 
Join PoLA on Facebook Join PoLA on LinkedIn and join PoLA forum
Partners:
National Lipid Association Polskie Towarzystwo Badań nad Miażdżycą American Society for Preventive Cardiology Polskie Towarzystwo Badań nad Otyłością
Home Events PoLA NEWS Journals Contact Polish Lipid Association
ul. Kleeberga 2
61-615 Poznań
tel./faks: +48 61 822 77 81
 © 2011 Polish Lipid Association. All rights reserved.